Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort

Background:Numerous cross-sectional studies have related exposure to neurotropic infectious agents with cognitive dysfunction in older adults, however, the temporal sequence is uncertain. Methods:In a representative, well-characterized, population-based aging cohort, we determined whether the temporal trajectories of multiple cognitive domains are associated with exposure to cytomegalovirus (CMV), Herpes Simplex virus, type 1 (HSV-1), Herpes Simplex virus, type 2 (HSV-2), or Toxoplasma gondii (TOX). Complex attention, executive functions, memory, language, and visuospatial function were assessed annually for 5 years among consenting individuals. Study entry IgG antibody titers indexing exposure to each infectious agent were examined in relation to slopes of subsequent temporal cognitive decline using multiple linear regressions adjusted for potential confounders. Results:The IgG levels for HSV-2 were significantly associated with baseline cognitive domain scores (N=1022 participants). Further, the IgG levels for HSV-2, TOX, and CMV, but not HSV-1 were significantly associated with greater temporal cognitive decline that varied by type of infection. Conclusions:Exposure to CMV, HSV-2, or TOX is associated with cognitive deterioration in older individuals, independent of general age–related variables. An increased understanding of the role of infectious agents in cognitive decline may lead to new methods for its prevention and treatment.

[1]  R. Yolken,et al.  Toxoplasma gondii and anxiety disorders in a community-based sample , 2015, Brain, Behavior, and Immunity.

[2]  David A Bennett,et al.  Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. , 2015, The Journal of infectious diseases.

[3]  Ruth F. Itzhaki,et al.  Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus , 2014, Front. Aging Neurosci..

[4]  F. Dickerson,et al.  Antibodies to Toxoplasma gondii and Cognitive Functioning in Schizophrenia, Bipolar Disorder, and Nonpsychiatric Controls , 2014, The Journal of nervous and mental disease.

[5]  J. Dowd,et al.  Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. , 2014, The Journal of infectious diseases.

[6]  M. Falkenstein,et al.  Toxoplasma gondii impairs memory in infected seniors , 2014, Brain, Behavior, and Immunity.

[7]  E. Masliah,et al.  Herpes virus in Alzheimer's disease: relation to progression of the disease , 2014, Neurobiology of Aging.

[8]  B. Snitz,et al.  Vascular Risk Factors and Cognitive Decline in a Population Sample , 2014, Alzheimer disease and associated disorders.

[9]  G. Pawelec,et al.  Human T Cell Aging and the Impact of Persistent Viral Infections , 2013, Front. Immunol..

[10]  David A. Bennett,et al.  Systemic Inflammation in Non-Demented Elderly Human Subjects: Brain Microstructure and Cognition , 2013, PloS one.

[11]  M. Pletnikov,et al.  Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. , 2012, Schizophrenia bulletin.

[12]  F. Dickerson,et al.  Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. , 2012, Schizophrenia bulletin.

[13]  L. Klei,et al.  Persistent infection with neurotropic herpes viruses and cognitive impairment , 2012, Psychological Medicine.

[14]  R. Yolken,et al.  Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis , 2012, Proceedings of the National Academy of Sciences.

[15]  F. Dickerson,et al.  Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia , 2012, Schizophrenia Research.

[16]  J. Lieberman,et al.  Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample , 2011, Schizophrenia Research.

[17]  Karl Herrup,et al.  Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.

[18]  F. Dickerson,et al.  Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia , 2010, Schizophrenia Research.

[19]  B. Snitz,et al.  Age and education effects and norms on a cognitive test battery from a population-based cohort: The Monongahela–Youghiogheny Healthy Aging Team , 2010, Aging & mental health.

[20]  B. Snitz,et al.  How much do depressive symptoms affect cognition at the population level? The monongahela–youghiogheny healthy aging team (MYHAT) study , 2009, International journal of geriatric psychiatry.

[21]  J. Cohen,et al.  Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice. , 2009, Virology.

[22]  J. Dowd,et al.  Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  F. Dickerson,et al.  Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia , 2008, Schizophrenia Research.

[24]  F. Dickerson,et al.  Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder , 2008, Brain, Behavior, and Immunity.

[25]  M. Haan,et al.  Persistent infection, inflammation, and functional impairment in older Latinos. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  C. Franceschi,et al.  Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects1 , 2007, The Journal of Immunology.

[27]  W. Flanders,et al.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  W. Jagust,et al.  The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years , 2006, Journal of the American Geriatrics Society.

[29]  T. Strandberg,et al.  Interaction of herpesviridae, APOE gene, and education in cognitive impairment , 2005, Neurobiology of Aging.

[30]  F. Dickerson,et al.  Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder , 2004, Biological Psychiatry.

[31]  T. Strandberg,et al.  Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. , 2003, Stroke.

[32]  F. Dickerson,et al.  Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. , 2003, Archives of general psychiatry.

[33]  G. Wilcock,et al.  Cytomegalovirus Is Present in a Very High Proportion of Brains from Vascular Dementia Patients , 2002, Neurobiology of Disease.

[34]  E. Schmutzhard.  Viral infections of the CNS with special emphasis on herpes simplex infections , 2001, Journal of Neurology.

[35]  B. Reed,et al.  Age and education correction of Mini-Mental State Examination for English- and Spanish-speaking elderly , 1996, Neurology.

[36]  N. Tan,et al.  Immunomodulation of cellular cytotoxicity to herpes simplex virus infection in pregnancy by inhibition of eicosanoid metabolism. , 1993, Journal of reproductive immunology.

[37]  H. Wiśniewski,et al.  Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia , 1979, Annals of neurology.

[38]  A. Havelaar,et al.  Intervention strategies to reduce human Toxoplasma gondii disease burden. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  D. Webster,et al.  Encephalitis in an immunocompetent man. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.